Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.51%
1,088.34
+5.54
+0.51%
—1,082.801,079.311,090.181,079.31——
SIXC
Communications
SIXC
Communications
SIXC
+0.86%
608.95
+5.18
+0.86%
—603.77603.77611.65602.09——
SIXE
Energy
SIXE
Energy
SIXE
-1.05%
1,198.51
-12.68
-1.05%
—1,211.191,203.051,203.051,182.72——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.28%
1,760.91
+4.92
+0.28%
—1,755.991,759.061,761.041,747.23——
SIXM
Financials
SIXM
Financials
SIXM
-0.90%
632.78
-5.73
-0.90%
—638.51637.93640.10631.89——
SIXR
Staples
SIXR
Staples
SIXR
+1.51%
855.73
+12.77
+1.51%
—842.96843.54858.44843.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.14%
219.59
+0.31
+0.14%
—219.28219.28220.58218.64——
SIXT
Technology
SIXT
Technology
SIXT
-0.65%
3,704.30
-24.05
-0.65%
—3,728.353,745.063,745.063,675.02——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.48%
911.09
-4.28
-0.48%
—915.48914.49915.84907.90——
SIXV
Health care
SIXV
Health care
SIXV
+0.33%
1,502.30
+4.85
+0.33%
—1,497.361,500.651,514.701,495.89——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.93%
2,459.74
+46.57
+1.93%
—2,413.172,431.692,463.522,431.69——
4554:TYO
Fuji Pharma Co Ltd
¥2,247.00
+2.46%
(+54.00) 1D
May 27, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4554...
Open
¥2,189
High
¥2,283
Low
¥2,173
Mkt. cap
59.64B
Avg. vol.
134.25K
Volume
157.60K
Dividend
2.02%
Quarterly dividend
¥11
Ex-dividend date
Sep 29, 2026
P/E ratio
22.74
52-wk high
¥2,559
52-wk low
¥1,277
EPS
¥99
Shares outstanding
29.92M
No. of employees
2K
News stories
From sources across the web
About Fuji Pharma Co Ltd
CEO-
Employees1.76K
FoundedApr 1, 1965
Headquarters-
SectorPharmaceutical industry
Websitefujipharma.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
12.86B
14.72B
15.90B
13.82B
Cost of goods sold
8.00B
8.71B
9.08B
8.30B
Cost of revenue
8.00B
8.71B
9.08B
8.30B
Research and development expenses
-
3.34B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.80B
-428.00M
4.03B
3.90B
Operating expense
3.80B
4.39B
4.03B
3.90B
Total operating expenses
11.80B
13.10B
13.11B
12.21B
Operating income
1.06B
1.62B
2.79B
1.61B
Other non operating income
-45.00M
68.00M
-47.00M
139.00M
EBT including unusual items
946.00M
1.30B
195.00M
489.00M
EBT excluding unusual items
909.00M
1.63B
2.65B
1.68B
Income tax expense
403.00M
133.00M
-129.00M
100.00M
Effective tax rate
-
10.21%
-66.15%
20.45%
Other operating expenses
-
-
-
-
Net income
543.00M
1.17B
324.00M
389.00M
Net profit margin
-
7.95%
2.04%
2.81%
Earnings per share
-
-
-
-
Interest and investment income
4.00M
-
-
1.00M
Interest expense
-95.00M
-100.00M
-84.00M
-105.00M
Net interest expenses
-91.00M
-100.00M
-84.00M
-104.00M
Depreciation and amortization charges
-
1.38B
-
-
EBITDA
1.98B
2.61B
3.78B
2.64B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer